Luca Magnani

28PUBLICATIONS
275CO-AUTHORS
Epigenetics (incl. genome methylation and epigenomics)Molecular targetsCheminformatics and quantitative structure-activity relationshipsPredictive and prognostic markersCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Jul 10, 2026
Correction: GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancer.

|Apr 29, 2026
GLYATL1 is associated with metabolic and epigenetic changes and with endocrine resistance in luminal breast cancer.

|Dec 09, 2025
Chemically modified CRISPR-Cas9 enables targeting of individual G-quadruplex and i-motif structures, revealing ligand-dependent transcriptional perturbation.

Sabrina Pia Nuccio, Enrico Cadoni, Roxani Nikoloudaki

|Jun 11, 2025
Epigenetic Heritability of Cell Plasticity Drives Cancer Drug Resistance through a One-to-Many Genotype-to-Phenotype Paradigm.

Erica A Oliveira, Salvatore Milite, Javier Fernandez-Mateos

|Oct 02, 2024
Induction of the TEAD Coactivator VGLL1 by Estrogen Receptor-Targeted Therapy Drives Resistance in Breast Cancer.

Carolina Gemma, Chun-Fui Lai, Anup K Singh

|May 16, 2024
A Functional Survey of the Regulatory Landscape of Estrogen Receptor-Positive Breast Cancer Evolution.

Iros Barozzi, Neil Slaven, Eleonora Canale

Pageof 5

Frequent Collaborators

8 joint publications

Andrea Sottoriva

6 joint publications

George D Cresswell

5 joint publications

Timon Heide

4 joint publications

Leandro Castellano